Pacientes
Socios

Biblioteca

Alertas Bibliográficas

DIABETES

Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani M, Maffei P, DeFronzo RA.
Lancet Diabetes Endocrinol. 2024 Aug 1:S2213-8587(24)00127-X. 
doi: 10.1016/S2213-8587(24)00127-X

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 
Phillip M, Achenbach P, Addala A et al.
Diabetes. Diabetes Care. 2024.
doi:10.2337/dci24-004

Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
Richard I G Holt, Clive S Cockram, Ronald C W Ma , Andrea O Y Luk
Diabetologia. 2024 Jul;67(7):1168-1180.
doi: 10.1007/s00125-024-06102-x

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R Tuttle, Peter Rossing, et al,N Engl J Med. 2024 May 24. 
doi: 10.1056/NEJMoa2403347

Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stephen I Stone, Ashok Balasubramanyam, Jennifer E Posey 
Diabetes Care. 2024 May 1;47(5):770-781. 
doi.org/10.2337/dci23-0038

ENDOCRINOLOGÍA​

Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
Eystein S Husebye, Frederik Castinetti, et al. 
Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21. 
https://doi.org/10.1530/EJE-22-0689

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret C S Boguszewski, Cesar L Boguszewski , et al. 
Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. 
https://doi.org/10.1530/EJE-21-1186

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
John P Bilezikian 1, Aliya A Khan, et al. 
J Bone Miner Res. 2022 Nov;37(11):2293-2314. 
https://doi.org/10.1002/jbmr.4677

Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Antonio Marcondes Lerario, Dipika R Mohan, Gary D Hammer, et al.  
Endocr Rev. 2022 Nov 25;43(6):1051-1073.
https://doi.org/10.1210/endrev/bnac012

PEDIATRÍA

The current state of long-acting growth hormone preparations for growth hormone therapy.
Yuen KCJ, Miller BS, Biller BMK.
Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):267-273.
http://doi.org/10.1097/MED.0000000000000416

Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.
Hoffmann A, Adelmann S, Lohle K, Claviez A, Müller HL.
Eur J Pediatr. 2018 Jan;177(1):125-132.
http://doi.org/10.1007/s00431-017-3042-5
Epub 2017 Nov 22.

Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literature.
Sentchordi-Montané L, Aza-Carmona M, Benito-Sanz S, Barreda-Bonis AC, Sánchez-Garre C, Prieto-Matos P et al.
Clin Endocrinol (Oxf). 2018 Jun;88(6):820-829.
http://doi.org/10.1111/cen.13581
Epub 2018 Mar 24.

Growth Outcomes After GH Therapy of Patients Given Long-Term Corticosteroids for Juvenile Idiopathic Arthritis.
David H, Aupiais C, Louveau B, Quartier P, Jacqz-Aigrain E, Carel JC, Simon D.
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4578-4587.
doi: http://doi.org/10.1210/jc.2017-01455

IHH Gene Mutations Causing Short Stature With Nonspecific Skeletal Abnormalities and Response to Growth Hormone Therapy
Vasques GA, Funari MFA, Ferreira FM, Aza-Carmona M, Sentchordi-Montané L, Barraza-García J et al.
J Clin Endocrinol Metab. 2018 Feb 1;103(2):604-614.
doi: http://doi.org/10.1210/jc.2017-02026

CIENCIAS BÁSICAS

Genetic testing for indeterminate thyroid cytology: review and meta-analysis.
Vargas-Salas S, Martínez JR, Urra S, Domínguez JM, Mena N, Uslar T, Lagos M, Henríquez M, González HE.
Endocr Relat Cancer. 2018 Mar; 25(3):R163-R177.
DOI: http://doi.org/10.1530/ERC-17-0405

Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?
Urra S, Fischer MC, Martínez JR, Véliz L, Orellana P, Solar A, Bohmwald K, Kalergis A, Riedel C, Corvalán AH, Roa JC, Fuentealba R, Cáceres CJ, López-Lastra M, León A, Droppelmann N, González HE.
Oncotarget. 2017 Dec 20; 9(2):2445-2467.
DOI: http://doi.org/10.18632/oncotarget.23502

11β-hydroxysteroid dehydrogenase-1 deficiency alters the gut microbiome response to Western diet.
Johnson JS, Opiyo MN, Thomson M, Gharbi K, Seckl JR, Heger A, Chapman KE.
J Endocrinol. 2017 Feb;232(2):273-283. Epub 2016 Nov 24. PMID:27885053
DOI: https://10.1530/JOE-16-0578

Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA, Hassan-Smith ZK, Doig CL, Sherlock M, Stewart PM, Lavery GG.
J Endocrinol. 2016 Jun;229(3):277-86. Epub 2016 Apr 5.
doi: https://10.1530/JOE-16-0011.